Hetero Drugs Ltd
Tofacitinib (5mg)
Jakura 5 Tablet is used to treat moderate to severe rheumatoid arthritis, psoriatic arthritis, ankylosing spondylitis, and ulcerative colitis.
Tablet
Jakura 5 Tablet may be prescribed by itself or in combination with another medicine. The tablets can be taken with or without food and it is best to take them at the same time each day. Your dose will depend on your condition and what other medicines you are taking. You should use it as your doctor tells you to. Do not stop taking this medicine unless your doctor tells you to because your condition could get worse.
Take this medicine in the dose and duration as advised by your doctor. Swallow it as a whole. Do not chew, crush or break it. Jakura 5 Tablet may be taken with or without food, but it is better to take it at a fixed time.
Jakura 5 Tablet is a Janus kinase inhibitor. It works by blocking the action of the enzyme Janus kinase. This decreases the activity of the immune system and inflammation associated with rheumatic diseases and ulcerative colitis.
Jakura 5 Tablet is used alone or in combination with other medicines for the treatment of rheumatoid arthritis that did not improve with other anti-rheumatic drugs. It may take 3 to 6 months to feel the maximum effect of this medication. Keep taking it as prescribed. Your doctor may get regular blood tests done to monitor your liver function, kidney function, blood counts, or cholesterol levels.
It's crucial to inform your doctor about any pre-existing liver conditions before taking Jakura 5 Tablet. This is because the medication can sometimes lead to elevated liver enzymes, potentially affecting liver function. While Jakura 5 Tablet may be suitable for patients with mild to moderate liver impairment, it should not be prescribed to those with severe liver impairment. Regular monitoring of liver function is essential in such cases.
Jakura 5 Tablet may increase the risk of certain cancers (like lymphoma and skin cancers) due to its effect on the immune system. If you have a history of any type of cancer, it's important to inform your doctor about this before starting Jakura 5 Tablet.
Jakura 5 Tablet is specifically approved for treating moderate to severe rheumatoid arthritis. This is an inflammatory condition affecting the joints. It's often used when previous treatments have been ineffective or unsuitable for the patient. Early use might be considered if a person doesn't respond well to standard medications. It can be used alone or combined with other medications like methotrexate.
It typically takes about two to eight weeks before you start feeling noticeable improvements after starting Jakura 5 Tablet. It may take three to six months to reach the full effect of this medication.
Before initiating Jakura 5 Tablet, your doctor will likely order blood tests. These tests can check for anemia (low red blood cell count), neutropenia or lymphopenia (low white blood cell count), high blood fat (cholesterol), and liver enzyme levels. This helps determine if the medication is safe and manageable.
Jakura 5 Tablet affects the immune system, potentially weakening your body's ability to fight infection. This can increase your susceptibility to various infections, including those caused by tuberculosis and severe fungal, bacterial, or viral infections. These infections can be life-threatening and should be treated promptly in a hospital setting.
No, you should not combine Tocilizumab with Jakura 5 Tablet. Both medications affect the immune system and using them together can increase the risk of infection and potential complications.